Showing 4271-4280 of 9578 results for "".
- ADCS Acquires Montgomery Dermatology; Catawba Research Enters Partnershiphttps://practicaldermatology.com/news/adcs-acquires-montgomery-dermatology-catawba-research-enters-partnership/2460565/Advanced Dermatology and Cosmetic Surgery (ADCS), the largest dermatology practice in the US, has acquired Dermatology Associates of Montgomery, a leading dermatology practice based in the Southeast. Bundy Group served as exclusive financial advisor to Dr. Steve Maddox, owner of Dermatology
- EB Research Partnership and EB Research Foundation Form Largest Global Organization Advancing EB Researchhttps://practicaldermatology.com/news/eb-research-partnership-and-eb-research-foundation-form-largest-global-organization-advancing-eb-research/2460559/EB Research Partnership (EBRP), based in New York, and EB Research Foundation (EBRF) of Australia are uniting to become the largest global organization focused on funding research to discover treatments and cures for Epidermolysis Bullosa (EB). As the two leading organiza
- With Label Extension, Simponi Aria Approved for PsA in Kids as Young as Twohttps://practicaldermatology.com/news/with-label-extension-simponi-aria-approved-for-psa-in-kids-as-young-as-two/2460549/The FDA has approved Simponi Aria (golimumab) for the treatment of active pJIA for patients two years of age and older and has extended the PsA indication for this same patient population. In Phase 3 clinical trials with pediatric patients, pharmacokinetic (PK) exposure of
- Practical Dermatology® magazine, Modern Aesthetics® magazine Recognized For Excellence by Folio: Magazinehttps://practicaldermatology.com/news/practical-dermatology-magazine-modern-aesthetics-magazine-recognized-for-excellence-by-folio-magazine/2460546/Bryn Mawr Communications III, LLC is pleased to announce that Practical Dermatology® magazine and sister publication Modern Aesthetics® magazine took home two Honorable Mentions from Folio: Magazine’s 2020 Eddie & Ozzie Awards, including a nod for Editorial Tea
- NEA Shares Educational Resources for October's Eczema Awareness Monthhttps://practicaldermatology.com/news/nea-shares-educational-resources-for-octobers-eczema-awareness-month/2460545/The National Eczema Association (NEA) is offering a robust series of virtual educational programs, patient/caregiver support experiences, community engagement activities and free resources throughout October's Eczema Awareness Month This year's month-long stakeholder engagement
- First Patient Enrolled in AVITA Therapeutic’s Pivotal Study of RECELL System for Vitiligohttps://practicaldermatology.com/news/first-patient-enrolled-in-avita-therapeutics-pivotal-study-of-recell-system-for-vitiligo/2460528/AVITA Therapeutics, Inc. a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs initiated its pivotal study assessing the use of the RECELL System to treat stable vitiligo with th
- New Allergan Aesthetics and Skinbetter Initiative Aims to Advance Health Equity and Diversity in Aestheticshttps://practicaldermatology.com/news/new-initiative-allergan-aesthetics-and-skinbetter-aims-to-advance-health-equity-and-diversity-in-aesthetics/2460526/Allergan Aesthetics, an AbbVie company, and Skinbetter Science have launched a new long-term, educational initiative—DREAM: Driving Racial Equity in Aesthetic Medicine—to further the principles of racial and ethnic diversity, inclusion, respect and understanding in the fields of derma
- Medicine X Launches Eczema Xplained Patient Story To Drive Understanding and Awareness of ADhttps://practicaldermatology.com/news/medicine-x-launches-eczema-xplained-patient-story-to-drive-understanding-and-awareness-of-ad/2460519/Medicine X today is launching Eczema Xplained, its first illustrated story in the U.S. on atopic dermatitis, the most comm
- Verrica Enters Agreement with Lytix for Oncolytic Peptide for Dermatologyhttps://practicaldermatology.com/news/verrica-enters-agreement-with-lytix-for-oncolytic-peptide-for-dermatology/2460498/Verrica Pharmaceuticals Inc. has entered into an exclusive worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology indications. Verrica intends to focus initially on basal cell and squamous cell carcinoma
- New Data Supports the Safety and Efficacy of Dupixent in Adults and Children with ADhttps://practicaldermatology.com/news/new-data-supports-the-safety-and-efficacy-of-dupixent-in-adults-and-children-with-ad/2460492/Two new studies reinforce the efficacy and safety of Dupixent for the treatment of atopic dermatitis in children and adults. In the Phase 3 LIBERTY AD pediatric trial data, nearly three times as many children achieved clear or almost clear skin when treated with Du